The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates have reached a major milestone with over 5000 volunteers having now received their first vaccination.
The 5000th vaccination was given in the presence of Dr Jamal Al Kaabi, the Acting Under-Secretary of Department of Health, Abu Dhabi, at the recently developed purpose-built walk-in registration, screening and testing centre at the Abu Dhabi National Exhibition Centre (ADNEC).
Dr Al Kaabi was the second participant in the vaccination programme and received his second shot this week.
The trials began in Abu Dhabi on July 16 and are being managed by G42 Healthcare in partnership with the Department of Health - Abu Dhabi, the UAE Ministry of Health and Prevention (MoHAP), and Abu Dhabi Health Services Company (SEHA).
The inactivated vaccine has been developed by Sinopharm CNBG, the world’s sixth-largest vaccine manufacturer.
A sense of nationwide pride and shared commitment has led to over 80 nationalities in the community already volunteering to participate, inspired by the UAE Leadership’s commitment to overcoming the pandemic through a global collaborative effort.
You can read up to 3 premium stories before you subscribe to Magzter GOLD
Log in, if you are already a subscriber
Get unlimited access to thousands of curated premium stories, newspapers and 5,000+ magazines
READ THE ENTIRE ISSUE
August 07, 2020